Bullatacin triggers immunogenic cell death of colon cancer cells by activating endoplasmic reticulum chaperones.

Fan, Fangtian; Shen, Peiliang; Ma, Yue; Ma, Wangbo; Wu, Hongyan; Liu, Hao; An, Qing.

Fan F; Anhui Engineering Technology Research Center of Biochemical Pharmaceuticals, School of Pharmacy, Bengbu Medical College, 2600 Donghai Avenue, Bengbu, 233003, Anhui, China. fftian3912@163.com.
Shen P; School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, 210023, China.
Ma Y; Anhui Engineering Technology Research Center of Biochemical Pharmaceuticals, School of Pharmacy, Bengbu Medical College, 2600 Donghai Avenue, Bengbu, 233003, Anhui, China.
Ma W; Anhui Engineering Technology Research Center of Biochemical Pharmaceuticals, School of Pharmacy, Bengbu Medical College, 2600 Donghai Avenue, Bengbu, 233003, Anhui, China.
Wu H; Institute of Biomedical Technology, Jiangsu Vocational College of Medicine, No.283 Jiefang South Road, Yancheng, 224005, China. why20133055@163.com.
Liu H; Anhui Engineering Technology Research Center of Biochemical Pharmaceuticals, School of Pharmacy, Bengbu Medical College, 2600 Donghai Avenue, Bengbu, 233003, Anhui, China.
An Q; Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, 210009, China.

J Inflamm (Lond) ; 18(1): 23, 2021 Jun 10.

Article en En | MEDLINE | ID: mdl-34112202